Companies: 10,795·Total market cap: $144.5T
NAYA Biosciences, Inc.

NAYA Biosciences, Inc.

NAYANASDAQHealthcare
$2.20
+$0.17(+8.37%)
Market Cap$1465323
P/E Ratio
52W High$17.04
52W Low$1.38

NAYA Biosciences, Inc.(NAYA)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · NAYA · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2024-122023-122022-122021-122020-12
Revenue
Revenue$6.53M$3.02M$0.82M$4.16M$1.04M
Cost of Revenue$3.66M$1.93M$0.85M$0.15M$0.09M
Gross Profit$2.87M$1.09M($0.03M)$4.02M$0.95M
Gross Margin %(computed)44.00%35.96%-3.48%96.51%91.44%
Operating Expenses
R&D Expenses$0.49M$0.17M$0.54M$0.22M$0.40M
G&A Expenses$0.00M$0.00M$0.00M$0.00M$0.00M
Total Operating Expenses$11.00M$7.65M$10.60M$9.23M$6.46M
Operating Income($8.13M)($6.77M)($10.63M)($5.22M)($5.51M)
Operating Margin %(computed)-124.40%-224.04%-125.39%-531.67%
Interest Income$0.00M$0.00M$0.00M$0.00M$0.00M
Interest Expense$1.06M$0.93M$0.06M$1.27M$2.84M
Income Before Tax($9.12M)($8.01M)($10.89M)($6.65M)($8.35M)
Income Tax Expense($0.02M)$0.03M$0.00M$0.00M$0.00M
Net Income($9.10M)($8.03M)($10.89M)($6.65M)($8.35M)
Net Margin %(computed)-139.25%-266.00%-159.97%-804.73%
Per Share & EBITDA
EPS (Basic)$-30.19$-5.13$-8.99$-6.26$-15.21
Wtd Avg Shares0.31M3.13M2.42M2.13M1.10M
EBITDA($7.14M)($6.88M)($10.75M)($5.22M)($5.48M)
EBITDA Margin %(computed)-109.35%-227.77%-125.45%-527.94%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · M

深入了解NAYA Biosciences, Inc.

关于NAYA Biosciences, Inc.(NAYA)损益表

NAYA Biosciences, Inc.(NAYA)损益表数据来源于SEC Form 10-K及10-Q申报文件。2024财年,NAYA实现营收$0.01B,毛利润$0.00B(毛利率44.00%),净利润($0.01B)(净利率-139.25%)。

常见问题

NAYA · 4 问

NAYA Biosciences, Inc.(NAYA)2024财年营收为$0.01B,同比up116.3%。

NAYA revenueNAYA salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09